title: Radiotherapy of primary cutaneous follicle center lymphoma: case report and review of literature.
abstract: Primary cutaneous follicle center lymphoma is an indolent primary cutaneous B-cell lymphoma originating from the follicle center cells, composed of a combination of centrocytes (small and large cleaved cells) and centroblasts (large noncleaved cells) with a follicular, follicular/diffuse, or diffuse growth pattern. Lesions are mostly located on the head, neck and trunk. A case is presented of a 56-year-old male patient with primary cutaneous follicle center lymphoma, with lesions involving the skin of the back, shoulders, presternal area and right forearm. As the patient presented a disseminated cutaneous form of the disease that involved several anatomical regions, complete work-up was followed by superficial fractionated radiotherapy of eight fields in VI expositions, with total irradiation dose of 1400 cGy upon the following fields: right and left pectoral region, left and right shoulders, right suprascapular region, and proximal third of the right forearm. Total irradiation dose applied upon each field for the lesions located on the left and right side of the back was 1500 cGy. This therapy resulted in significant reduction of visible tumor. The patient was regularly followed up on outpatient basis for 12 months of radiotherapy, being free from local recurrence and systemic spread of the disease.
authors.forename: Romana
authors.initials: R
authors.lastname: Ceovic
authors.forename: Ivana
authors.initials: I
authors.lastname: Jovanovic
authors.forename: Kresimir
authors.initials: K
authors.lastname: Kostovic
authors.forename: Jaka
authors.initials: J
authors.lastname: Rados
authors.forename: Snjezana
authors.initials: S
authors.lastname: Dotlic
authors.forename: Ivo
authors.initials: I
authors.lastname: Radman
authors.forename: Sandra Marinovic
authors.initials: SM
authors.lastname: Kulisic
authors.forename: Davorin
authors.initials: D
authors.lastname: Loncaric
mesh_terms: D019583:Dose Fractionation, Radiation; D006801:Humans; D016393:Lymphoma, B-Cell / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000532:radiotherapy*